Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy in Phase 1 Trial Targeting Metastatic Breast Cancer
In a groundbreaking advancement poised to reshape cancer therapy, researchers at the Calibr-Skaggs Institute for Innovative Medicines, part of the ...
